Rayonex Biomedical GmbH

Rayonex Biomedical GmbH is a German medical device manufacturer established in 1982, specializing in bioresonance therapy devices based on the treatment methodology of Bioresonance according to Paul Schmidt. The company manufactures Class I and IIa medical devices certified to DIN EN ISO 13485 and audited annually by TÜV Nord. Products include the Rayocomp PS 1000 polar 4.0 med. (high-end bioresonance device with ECG-based Rayoscan® diagnostic capability for biofeedback analysis) and the portable Rayocomp PS 10 med. for home use. The bioresonance approach is based on cellular stimulation to support organismal self-regulation; the company has recorded over 3,600 frequency spectra for human and veterinary applications. A double-blind, randomized, placebo-controlled clinical study demonstrated efficacy in treating chronic cervical spine syndrome pain. Beyond medical applications, Rayonex produces non-medical bioresonance devices for veterinary medicine, building biology, and wellness; biofield formers; and nutritional supplements containing minerals, trace elements, vitamins, and probiotic cultures. Manufacturing is CO2-neutral and utilizes high-precision robotics at the company's Lennestadt facility in Germany's Sauerland region. Products are distributed in 46 countries; over 10 million treatments are performed annually with Rayonex devices. The company also offers certified practitioner training courses in Bioresonance according to Paul Schmidt for healthcare professionals. While scientific studies support efficacy, bioresonance remains a complementary therapy not yet officially recognized by conventional medicine.